PhosLo (calcium acetate) is a new phosphate binder available for the prevention and management of hyperphosphataemia in patients with advanced renal failure on dialysis.

The usual starting dose is two capsules with each meal, increasing until the desired phosphate level is achieved; most patients will require three or four capsules with each meal to achieve adequate control of phosphate levels.

View PhosLo drug record

Further information: Fresenius

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in